Skip to content

Clinical trials

Phase 3 Diabetes Mellitus trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Diabetes Mellitus Phase: Phase 3 Country / region: South Korea Clear all

49 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20063
20073
20084
20098
20106
20116
20133
20143
20162
20173
20182
20201
20221
20231
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed41
Terminated5
Recruiting2
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novo Nordisk A/S15
AstraZeneca10
Eli Lilly and Company5
Allergan3
Takeda3
GlaxoSmithKline2
Janssen Research & Development, LLC2
Amgen1
Bristol-Myers Squibb1
Chonbuk National University Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Diabetes Mellitus49
Diabetes Mellitus, Type 236
Glucose Metabolism Disorders4
Metabolic Diseases4
Endocrine System Diseases3
Gastroparesis3
Coronary Artery Disease2
Obesity2
Overweight2
Vomiting2

Trials

Showing 1 to 25 of 49. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.